Microbiome Modulation With Prebiotics in PTSD and Cirrhosis
Public ClinicalTrials.gov record NCT06464952. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Structure and Function of Microbiome Change in Subjects With Cirrhosis and PTSD After Potato Starch or Cellulose Supplementation (RESIST-PTSD)
Study identification
- NCT ID
- NCT06464952
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 30 participants
Conditions and interventions
Interventions
- Powdered cellulose Dietary Supplement
- Resistant potato starch Dietary Supplement
Dietary Supplement
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 30, 2024
- Primary completion
- Jun 24, 2027
- Completion
- Sep 24, 2027
- Last update posted
- Apr 8, 2026
2024 – 2027
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hunter Holmes McGuire VA Medical Center | Richmond | Virginia | 23249 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Recently updated Cirrhosis trials
Other public records listing Cirrhosis. Sorted by last update posted; newest first. Not a recommendation.
- NCT07029243: Prehab and Creatine/Whey Supplementation in Frailty Among Patients With Cirrhosis Recruiting
- NCT06941415: Bumetanide vs. Furosemide in Cirrhosis Recruiting
- NCT05548452: Intestinal Microbiota Transplant in Alcohol-Associated Liver Disease Recruiting
- NCT07568275: Comparison of Angiotensin II to Standard Dose Vasopressors on Change in Arterial Elastance Active, not recruiting
- NCT02968810: Simvastatin in Preventing Liver Cancer in Patients With Liver Cirrhosis Active, not recruiting
- NCT05170854: The Impact of Liver Cirrhosis on Outcomes in Trauma Patients Active, not recruiting
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06464952, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 8, 2026 · Synced May 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06464952 live on ClinicalTrials.gov.